Pneumocystis jirovecii dihydrofolate reductase polymorphisms associated with failure of prophylaxis.
Nahimana
Aimable
A
Hospital Preventive Medicine, University Hospital, 1011 Lausanne, Switzerland. Aimable.Nahimana@chuv.hospvd.ch
Rabodonirina
Meja
M
Francioli
Patrick
P
Bille
Jacques
J
Hauser
Philippe M
PM
D019943:Amino Acid Substitution; D000935:Antifungal Agents / Q000627:therapeutic use; D006801:Humans; D020125:Mutation, Missense; D045363:Pneumocystis carinii / Q000201:enzymology / Q000235:genetics*; D011020:Pneumonia, Pneumocystis / Q000235:genetics / Q000517:prevention & control*; D011110:Polymorphism, Genetic; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000935:Antifungal Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D013762:Tetrahydrofolate Dehydrogenase